Responses to parliamentary questions
Question from Deputy Conor Sheehan - PQ 49595-26
Deputy Sheehan asked if mounjaro and wegovy are being evaluated for severe metabolic and endocrine conditions alongside obesity. Read the HSE response.
From: Communications and Public Affairs
Published: June 2026
Updated: September 2026
Documents
Summary
To ask the Minister for Health if the NCPE is evaluating the application of mounjaro and wegovy for severe metabolic and endocrine conditions alongside obesity; and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it